Similarly, the inhibitors against heat shock factor 1, an activator of PROM2 transcription, can sensitize cancer cells to ferroptosis-inducing drugs and alleviate the oncogenic and ferroptosis resistance programs 37. This evidence concerns the gene PROM2 and cancer.